This new nerve pain formulation l feel will be the catalyst to have major investors/fund managers take ZLD as a serious player they will be watching for further developments regarding this and Autism both are major game changers though l feel maybe 12 to 18 months away yet lets just hope our management dont screw it up we could actually see some serious coin within the above time frame
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica, page-193
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
-0.010(2.17%) |
Mkt cap ! $5.106M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 46.0¢ | 45.0¢ | $1.962K | 4.359K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 143 | 1 |
View Market Depth
| Last trade - 15.32pm 10/06/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |